Biophytis S.A. (EPA:ALBPS)
France · Delayed Price · Currency is EUR 0.1050
-0.0210 (-16.67%)
Aug 21, 2026, 5:35 PM CET
Biophytis Market Cap
Biophytis has a market cap or net worth of €9.62 million as of August 21, 2026. Its market cap has increased by 133.54% in one year.
Market Cap
9.62M
Enterprise Value
16.10M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.11
ChartMarket Cap Chart
Since July 13, 2015, Biophytis's market cap has decreased from 45.17M to 9.62M, a decrease of -78.70%. That is a compound annual growth rate of -12.99%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 9.62M | 521.90% |
| Dec 31, 2025 | 1.55M | -44.45% |
| Dec 31, 2024 | 2.78M | -23.40% |
| Dec 29, 2023 | 3.64M | -51.74% |
| Dec 30, 2022 | 7.53M | -87.89% |
| Dec 31, 2021 | 62.22M | -32.26% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| GenSight Biologics | 24.67M |
| Advicenne | 24.44M |
| genOway Société anonyme | 22.59M |
| Aelis Farma | 14.66M |
| Aton | 12.59M |
| NFL Biosciences | 10.90M |
| Poxel | 10.54M |
| TME Pharma | 8.26M |